Table 2.
Age | Gender | Smoking | Alcohol | Tumor Site | Tumor Size | DTCD | LNM | Pathological Type | Pathological Stage | Ki-67 PP | p53 PP | nm23 PP | PABPC1 PP | Outcome (Death) | Tumor Recurrence | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age | \ | 0.091 | −0.139 | 0.009 | −0.054 | −0.166 * | 0.004 | −0.13 | −0.055 | −0.051 | 0.035 | 0.113 | −0.093 | 0.102 | 0.072 | −0.052 |
Gender | 0.091 | \ | −0.365** | −0.361** | −0.179** | −0.02 | 0.008 | −0.116 | 0.025 | −0.07 | 0.106 | 0.024 | 0.112 | 0.061 | −0.010 | −0.024 |
Smoking | −0.139 | −0.365** | \ | 0.729** | 0.01 | 0.045 | −0.061 | 0.107 | 0.084 | −0.026 | −0.083 | −0.18 * | −0.067 | −0.045 | 0.055 | 0.014 |
Alcohol | 0.009 | −0.361** | 0.729** | \ | −0.043 | 0.005 | −0.121 | 0.12 | 0.096 | −0.009 | −0.062 | −0.066 | −0.086 | −0.105 | 0.206 * | 0.14 |
Tumor site | −0.054 | −0.179** | 0.010 | −0.043 | \ | 0.197** | 0.004 | 0.1 | 0 | 0.088 | 0.025 | 0.081 | 0.007 | −0.075 | −0.075 | −0.061 |
Tumor size | −0.166 * | −0.020 | 0.045 | 0.005 | 0.197** | \ | 0.111 | 0.198** | 0.007 | 0.241** | 0.112 | 0.145 * | −0.005 | −0.049 | 0.072 | 0.174 * |
DTCD | 0.004 | 0.008 | −0.061 | −0.121 | 0.004 | 0.111 | \ | 0.273** | −0.026 | 0.313** | 0.215** | 0.113 | −0.0.103 | 0.124 | 0.152 | 0.204 * |
LNM | −0.13 | −0.116 | 0.107 | 0.12 | 0.1 | 0.198** | 0.273** | 1 | 0.034 | 0.822** | 0.139 * | 0.061 | −0.165 * | 0.166 * | 0.481** | 0.499** |
Pathological type | −0.055 | 0.025 | 0.084 | 0.096 | 0 | 0.007 | −0.026 | 0.034 | \ | 0.039 | 0.041 | 0.080 | −0.013 | 0.076 | 0.007 | −0.030 |
Pathological stage | −0.051 | −0.070 | −0.026 | −0.009 | 0.088 | 0.241** | 0.313** | 0.822** | 0.039 | \ | 0.105 | 0.108 | −0.139 * | 0.136 * | 0.504** | 0.514** |
Ki-67 PP | 0.035 | 0.106 | −0.083 | −0.062 | 0.025 | 0.112 | 0.215** | 0.139 * | 0.041 | 0.105 | \ | −0.008 | 0.050 | 0.025 | 0.033 | 0.064 |
p53 PP | 0.113 | 0.024 | −0.18 * | −0.066 | 0.081 | 0.145 * | 0.113 | 0.061 | 0.08 | 0.108 | −0.008 | \ | −0.133 * | 0.001 | 0.017 | −0.041 |
nm23 PP | −0.093 | 0.112 | −0.067 | −0.086 | 0.007 | −0.005 | −0.0.103 | −0.165 * | −0.013 | −0.139 * | 0.05 | −0.133 * | \ | −0.076 | −0.100 | −0.087 |
PABPC1 PP | 0.102 | 0.061 | −0.045 | −0.105 | −0.075 | −0.049 | 0.124 | 0.166 * | 0.076 | 0.136 * | 0.025 | 0.001 | −0.076 | \ | 0.384** | 0.337** |
Outcome (death) | 0.072 | −0.010 | 0.055 | 0.206 * | −0.075 | 0.072 | 0.152 | 0.481** | 0.007 | 0.504** | 0.033 | 0.017 | −0.100 | 0.384** | \ | 0.747** |
Tumor recurrence | −0.052 | −0.024 | 0.014 | 0.14 | −0.061 | 0.174 * | 0.204 * | 0.499** | −0.03 | 0.514** | 0.064 | −0.041 | −0.087 | 0.337** | 0.747** | \ |
Notes: Correlation between the parameters except “outcome” and “tumor recurrence” was based on the data from all the 231 patients. * at p<0.05 level, ** at p<0.01 level.
Abbreviations: ESCC, esophageal squamous cell carcinoma; DTCD, degree of tumor cell differentiation; LNM, lymph node metastasis; PP, percentage of positive tumor cells relative to the total number of tumor cells.